These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1542 related items for PubMed ID: 7669729

  • 1. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT, Johnson MD, Merlino G, Smith GH, Dickson RB.
    Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
    [Abstract] [Full Text] [Related]

  • 2. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ, Weaver Z, Deming S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T, Dickson RB.
    Oncogene; 1998 May 28; 16(21):2755-66. PubMed ID: 9652742
    [Abstract] [Full Text] [Related]

  • 3. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis.
    Amundadottir LT, Nass SJ, Berchem GJ, Johnson MD, Dickson RB.
    Oncogene; 1996 Aug 15; 13(4):757-65. PubMed ID: 8761297
    [Abstract] [Full Text] [Related]

  • 4. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
    Bocchinfuso WP, Hively WP, Couse JF, Varmus HE, Korach KS.
    Cancer Res; 1999 Apr 15; 59(8):1869-76. PubMed ID: 10213494
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells.
    Smith GH, Sharp R, Kordon EC, Jhappan C, Merlino G.
    Am J Pathol; 1995 Oct 15; 147(4):1081-96. PubMed ID: 7573353
    [Abstract] [Full Text] [Related]

  • 6. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E, Nagy P, Jensen MR, Factor VM, Thorgeirsson SS.
    Am J Pathol; 1996 Aug 15; 149(2):407-28. PubMed ID: 8701981
    [Abstract] [Full Text] [Related]

  • 7. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia.
    Daphna-Iken D, Shankar DB, Lawshé A, Ornitz DM, Shackleford GM, MacArthur CA.
    Oncogene; 1998 Nov 26; 17(21):2711-7. PubMed ID: 9840935
    [Abstract] [Full Text] [Related]

  • 8. TGF beta regulation of cell proliferation.
    Moses HL, Arteaga CL, Alexandrow MG, Dagnino L, Kawabata M, Pierce DF, Serra R.
    Princess Takamatsu Symp; 1994 Nov 26; 24():250-63. PubMed ID: 8983080
    [Abstract] [Full Text] [Related]

  • 9. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ, Natarajan G, Deming SL, Jamerson MH, Johnson M, Chepko G, Dickson RB.
    Oncogene; 2000 Mar 02; 19(10):1307-17. PubMed ID: 10713672
    [Abstract] [Full Text] [Related]

  • 10. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
    Elson A, Deng C, Campos-Torres J, Donehower LA, Leder P.
    Oncogene; 1995 Jul 06; 11(1):181-90. PubMed ID: 7624126
    [Abstract] [Full Text] [Related]

  • 11. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene.
    Böttinger EP, Jakubczak JL, Haines DC, Bagnall K, Wakefield LM.
    Cancer Res; 1997 Dec 15; 57(24):5564-70. PubMed ID: 9407968
    [Abstract] [Full Text] [Related]

  • 12. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
    Krane IM, Leder P.
    Oncogene; 1996 Apr 18; 12(8):1781-8. PubMed ID: 8622899
    [Abstract] [Full Text] [Related]

  • 13. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
    Forrester E, Chytil A, Bierie B, Aakre M, Gorska AE, Sharif-Afshar AR, Muller WJ, Moses HL.
    Cancer Res; 2005 Mar 15; 65(6):2296-302. PubMed ID: 15781643
    [Abstract] [Full Text] [Related]

  • 14. Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model.
    Reddy KB, McGowen R, Schuger L, Visscher D, Sheng S.
    Oncogene; 2001 Oct 04; 20(45):6538-43. PubMed ID: 11641778
    [Abstract] [Full Text] [Related]

  • 15. Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice.
    Lane TF, Leder P.
    Oncogene; 1997 Oct 04; 15(18):2133-44. PubMed ID: 9393971
    [Abstract] [Full Text] [Related]

  • 16. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc.
    Nass SJ, Dickson RB.
    Clin Cancer Res; 1998 Jul 04; 4(7):1813-22. PubMed ID: 9676860
    [Abstract] [Full Text] [Related]

  • 17. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.
    Kitsberg DI, Leder P.
    Oncogene; 1996 Dec 19; 13(12):2507-15. PubMed ID: 9000125
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.
    Kirma N, Luthra R, Jones J, Liu YG, Nair HB, Mandava U, Tekmal RR.
    Cancer Res; 2004 Jun 15; 64(12):4162-70. PubMed ID: 15205327
    [Abstract] [Full Text] [Related]

  • 19. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
    Vail ME, Pierce RH, Fausto N.
    Cancer Res; 2001 Jan 15; 61(2):594-601. PubMed ID: 11212255
    [Abstract] [Full Text] [Related]

  • 20. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis.
    Murakami H, Sanderson ND, Nagy P, Marino PA, Merlino G, Thorgeirsson SS.
    Cancer Res; 1993 Apr 15; 53(8):1719-23. PubMed ID: 8467484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 78.